Cargando…
Diagnosing Tuberculosis: What Do New Technologies Allow Us to (Not) Do?
New tuberculosis (TB) diagnostics are at a crossroads: their development, evaluation, and implementation is severely damaged by resource diversion due to COVID-19. Yet several technologies, especially those with potential for non-invasive non-sputum-based testing, hold promise for efficiently triagi...
Autores principales: | Abdulgader, Shima M., Okunola, Anna O., Ndlangalavu, Gcobisa, Reeve, Byron W.P., Allwood, Brian W., Koegelenberg, Coenraad F.N., Warren, Rob M., Theron, Grant |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9533455/ https://www.ncbi.nlm.nih.gov/pubmed/35760050 http://dx.doi.org/10.1159/000525142 |
Ejemplares similares
-
Clinical utility of C-reactive protein-based triage for presumptive pulmonary tuberculosis in South African adults
por: Calderwood, Claire J, et al.
Publicado: (2023) -
The significance of non‐occupational asbestos exposure in women with mesothelioma
por: Tlotleng, Nonhlanhla, et al.
Publicado: (2018) -
Blood RNA biomarkers for tuberculosis screening in people living with HIV prior to anti-retroviral therapy initiation: A diagnostic accuracy study
por: Mann, Tiffeney, et al.
Publicado: (2023) -
Different disease, same challenges: Social determinants of tuberculosis and COVID-19
por: Duarte, R., et al.
Publicado: (2021) -
Assisted mobilisation in critical patients with COVID-19
por: Polastri, M., et al.
Publicado: (2021)